// IP Marketing video - START// IP Marketing video - END

U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
Armenia is ranked 86th overall in the world in making progress towards the United Nations’ health-related Sustainable Development Goals.
HayPost’s new stamps have been printed in Cartor Printing House, France, with face values of AMD200 and AMD300.
On September 21, 1991, a referendum on Armenia’s secession from the USSR was held, with 94.99% of the people voting for independence.
Deputy Prime Minister and Minister for International Economic Integration and Reforms Vache Gabrielyan retained his post
Partner news